News

Launch of WeylChem InnoTec – The Technology and Innovation backbone of WeylChem Group of Companies

04. August 2017

Starting August 1st a new Chemical Service Company within the WeylChem Group of Companies has been formed. With its competencies in Analytics, Contract Research and Piloting as well as Specialized Custom Synthesis and Process development WeylChem InnoTec, a carve-out of Allessa GmbH, will serve customers in the chemical and related industries.

WeylChem InnoTec complements our offering perfectly,” says Frank Wegener, President of WeylChem Group of Companies. “By combining Analytics, R&D and Piloting activities of our Frankfurt entities, we are enhancing the service offer to our customers and creating further synergies within our Group”.

“Our mission is to be the innovative partner to the fine chemical and pharmaceutical industry providing world-class services,” adds Bernhard Müller, Managing Director of WeylChem InnoTec. “Our name implies that we are the dynamic and innovative partner of choice for our customers thanks to our flexible and streamlined structures.  

The company will be headquartered in Frankfurt Fechenheim and the Business Unit Custom Synthesis in the Industrial Park Höchst. Bernhard Müller and Ottmar Wink have been appointed Managing Directors of the new company, with a headcount of approximately 120 employees.

 

About WeylChem Group of Companies
WeylChem Group of Companies is the fine chemicals platform of International Chemicals Investors Group. With ten companies in Europe and North America, WeylChem employs more than 1,970 people. The Group is a global leader in custom manufacturing of specialty chemicals and supplies its customers with a wide range of advanced intermediates and reagents for diverse applications.

For more information about WeylChem Group: www.weylchem.com

Contact:

WeylChem

Lejla Skaljic
Phone: +49 60 506 820 2587

Email: lejla.skaljic@weylchem.com

About International Chemical Investors Group
International Chemical Investors is a privately owned industrial group with sales in excess of EUR 2 billion and more than 6,000 employees worldwide. ICIG is focusing on three main platforms: Pharmaceuticals under the CordenPharma brand, Fine Chemicals under the WeylChem brand and Chlorovinyls under the VYNOVA brand. Since inception in 2004, ICIG has acquired 25 independent chemicals and pharmaceutical businesses in Europe and the United States, all of which have origins in major global chemical or pharmaceutical corporations.

For more information about International Chemical Investors Group: www.ic-investors.com.

Contact:

International Chemical Investors Group
Sibel Cumcu
An der Hauptwache 5
60313 Frankfurt
Phone: +49 69 506 999 0
Email: info@ic-investors.com

back